At June 30, 2026 and December 31, 2025, accrued expenses consisted of the following (in thousands):
As of June 30, 2026
As of December 31, 2025
Accrued compensation
$
20,098
9,467
Accrued clinical trial costs
13,368
8,336
Accrued other research and development costs
303
1,238
Professional services
2,893
895
Other accruals
560
510
Total
37,222
20,446
No definition available.
Tabular disclosure of the components of accrued liabilities.